Global Allergy Diagnostics Market Size By Type (Kit, Instrument), By Application (food allergy, Skin sensibility), By Region, And Segment Forecasts, 2023 to 2032

The Global Allergy Diagnostics Market was valued at USD 5.6 billion in 2023 and is projected to reach USD 10.4 billion by 2031, growing at a CAGR of 8.1% during the forecast period from 2023 to 2031. The market growth is primarily driven by the increasing prevalence of allergic diseases, rising healthcare awareness, and technological advancements in diagnostic testing. Allergy diagnostics play a crucial role in identifying allergen-specific immunoglobulin E (IgE) antibodies, enabling precise diagnosis and personalized treatment of allergies. The demand for allergy diagnostics is further fueled by changing environmental conditions, increasing pollution levels, and lifestyle changes contributing to a surge in allergic conditions globally.

Drivers

Rising Prevalence of Allergic Diseases

The increasing incidence of respiratory allergies, food allergies, drug allergies, and skin allergies globally is driving the demand for accurate and reliable allergy diagnostic solutions.

Technological Advancements in Allergy Testing

Innovations in allergy diagnostic techniques such as component-resolved diagnostics (CRD), multiplex assays, and advanced immunoassay platforms have enhanced the accuracy, sensitivity, and speed of allergy testing.

Growing Healthcare Expenditure

Rising healthcare spending, especially in emerging economies, is supporting the adoption of advanced allergy diagnostic tests, promoting early diagnosis and effective management of allergic conditions.

Restraints

High Cost of Allergy Diagnostic Tests

The high cost associated with advanced allergy testing solutions, including laboratory equipment and testing kits, can limit market growth, especially in price-sensitive regions.

Lack of Awareness in Developing Regions

Limited awareness regarding allergic diseases and available diagnostic options in certain developing regions can hinder market expansion.

Opportunity

Market Expansion in Emerging Economies

Emerging economies in Asia-Pacific and Latin America present significant growth opportunities due to improving healthcare infrastructure, increasing awareness about allergies, and rising disposable incomes.

Development of Point-of-Care Allergy Testing

The growing demand for point-of-care allergy testing solutions, enabling rapid and accurate diagnosis at primary healthcare centers and home settings, offers lucrative growth prospects for market players.

Market by System Type Insights

Based on system type, the In-Vitro Allergy Testing segment dominated the market in 2023, driven by its high accuracy, convenience, and ability to detect multiple allergens from a single sample. However, the In Vivo Allergy Testing segment, including skin prick tests and intradermal tests, continues to hold a substantial market share due to its widespread use in clinical settings.

Market by End-use Insights

Based on end-use, the Diagnostic Laboratories segment emerged as the largest revenue contributor in 2023, accounting for over 45% of the market share. The increasing number of allergy testing laboratories and growing patient preference for laboratory-based diagnostics are fueling this segment's growth. The Hospitals segment is also expected to witness significant growth owing to the rising number of allergy patients seeking specialized care.

Market by Regional Insights

North America dominated the global allergy diagnostics market in 2023, driven by advanced healthcare infrastructure, high awareness levels, and a strong presence of leading market players. However, the Asia-Pacific region is anticipated to register the highest CAGR during the forecast period, supported by rising allergic disease prevalence, increasing healthcare investments, and growing demand for diagnostic services in countries like China and India.

Competitive Scenario

Key players operating in the Global Allergy Diagnostics Market include Thermo Fisher Scientific Inc., Siemens Healthineers AG, Danaher Corporation, Omega Diagnostics Group PLC, Stallergenes Greer, HOB Biotech Group Corp., Ltd., R-Biopharm AG, BioMerieux SA, Hitachi Chemical Diagnostics Inc., and Hycor Biomedical Inc. These companies are focusing on strategic partnerships, technological advancements, product innovations, and geographical expansion to strengthen their market position.

Scope of Work – Global Allergy Diagnostics Market

Report Metric Details

Market Size (2023) USD 5.6 Billion

Projected Market Size (2031) USD 10.4 Billion

CAGR (2023-2031) 8.1%

Key Segments by System Type In-Vitro Allergy Testing, In Vivo Allergy Testing

Key Segments by End-use Diagnostic Laboratories, Hospitals, Clinics

Leading Region North America

Key Players Thermo Fisher Scientific, Siemens Healthineers, Danaher Corporation, Omega Diagnostics, Stallergenes Greer

Key Market Developments

In 2023, Thermo Fisher Scientific launched its next-generation Phadia 2500+ allergy testing platform, enhancing the efficiency and scalability of allergy diagnostics.

Siemens Healthineers announced the development of a multiplex allergy testing solution in 2022, enabling simultaneous detection of multiple allergens.

Omega Diagnostics expanded its allergy testing portfolio in 2024 through strategic collaborations with regional diagnostic laboratories in Asia-Pacific.

FAQs

1. What is the current market size of the Global Allergy Diagnostics Market?

The Global Allergy Diagnostics Market was valued at USD 5.6 billion in 2023.

2. What is the major growth driver of the Global Allergy Diagnostics Market?

The rising prevalence of allergic diseases and technological advancements in diagnostic testing are the key growth drivers of the market.

3. Which is the largest region during the forecast period in the Global Allergy Diagnostics Market?

North America is expected to maintain its position as the largest region during the forecast period.

4. Which segment accounted for the largest market share in the Global Allergy Diagnostics Market?

The In-Vitro Allergy Testing segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Allergy Diagnostics Market?

Key players include Thermo Fisher Scientific Inc., Siemens Healthineers AG, Danaher Corporation, Omega Diagnostics Group PLC, and Stallergenes Greer.